Barclays Maintains Overweight on MasTec, Raises Price Target to $106
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Adam Seiden has maintained an Overweight rating on MasTec (NYSE:MTZ) and increased the price target from $55 to $106, indicating a positive outlook on the company's stock.
March 05, 2024 | 3:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Adam Seiden has reaffirmed an Overweight rating on MasTec and raised the price target from $55 to $106.
The increase in price target by a reputable analyst suggests a strong bullish sentiment towards MasTec's stock. This is likely to positively influence investor perception and could lead to a short-term increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100